Gastroenterology
Volume 133, Issue 5 , Pages 1744-1745 , November 2007

Importance of the Australian Crohn’s Disease Antibiotic Study

References 

  1. Selby W, Pavill P, Crotty B, et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn’s disease. Gastroenterology. 2007;132:2313–2319
  2. Peyrin-Biroulet L, Neut C, Columbel JF. Antimycobacterial therapy in Crohn’s disease; game over?. Gastroenterology. 2007;132:2594–2598
  3. Greenstein RJ, Liya S, Haroutunian V, et al. On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis. PLos One. 2007;2:e161
  4. Greenstein RJ, Su L, Shahidi A, et al. On the action of 5-amino-salicylic acid and sulfapyridine on M. avium subspecies paratuberculosis. PLos One. 2007;2:e516
  5. Mannon P. Gain for loss: adalimubab for infliximab-refractory Crohn disease. Ann Intern Med. 2007;146:888–890
  6. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn’s disease: the Accent/Randomised trial. Lancet. 2002;359:1541–1549

PII: S0016-5085(07)01654-X

doi: 10.1053/j.gastro.2007.09.013

Gastroenterology
Volume 133, Issue 5 , Pages 1744-1745 , November 2007

Article Tools